| Report ID | 283128 |
| Drug Identification Number | 02267233 |
| Brand name | TECTA |
| Common or Proper name | Pantoprazole magnesium |
| Company Name | TAKEDA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PANTOPRAZOLE |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL ORAL |
| Packaging size | Blisters - 30 count |
| Anatomical Therapeutical Chemical (ATC) code | A02BC |
| Anatomical Therapeutical Chemical (ATC) description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2026-04-19 |
| Actual start date | 2026-04-16 |
| Estimated end date | 2026-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-04-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-16 | French | Compare |
| v1 | 2026-04-16 | English | Compare |
Showing 1 to 2 of 2